A Year's Struggle: How Japan Is Recovering Damaged Generic Supplies After Quality Violations

Group Points To Pricing Risks

12 Apr 2022

Japan struggles to recover its ever-expanding supply chain for generic drugs after several key players had their production stopped because of a series of GMP violations. As the share of generics grows under government policy, some in the industry argue the problems are deeply rooted in a decades-old pricing system.

Japan has struggled to recover distribution of generic drug over an year — Japan Tries To Recover Generic Drug Distribution • Source: Alamy

The Japanese government and associations of domestic firms are trying to improve quality control and bring back stable distribution to the generics sector.

While the country has almost reached its volume share goal of 80% to reduce ever-rising healthcare costs, a supply shortage...